Pharmacology

Action Mechanism of Action Reference
INHIBITOR T-cell immunoreceptor with Ig and ITIM domains inhibitor Other Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Esophageal Neoplasms 3 D004938 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Small Cell Lung Carcinoma 3 D055752 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Stomach Neoplasms 1 D013274 ClinicalTrials
Triple Negative Breast Neoplasms 1 D064726 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Liver Neoplasms 1 D008113 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298050
FDA SRS 6XG22YQM2Z